An observational study in Paraesophageal Hernia, sponsored by Corewell Health West. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-09-29.
Sponsored by Corewell Health West · Observational
Paraesophageal hernia can cause significant clinical symptoms, including reflux, chest pain, nausea, regurgitation, and even life threatening conditions such as bowel obstruction, and gastric volvulus. Repair of a paraesophageal hernia is associated with significant recurrence rate, with primary repair often in excess of 50%. Hernia recurrence and revisional surgery significantly increase the likelihood of complications and decreased quality of life.
87 studies on the registry are indexed under Hernia, Hiatal; 27 are open to participants now.
This study's planned enrollment of 42 is below the median of 151 across 29 observational studies indexed under Hernia, Hiatal.
Browse Hernia, Hiatal studies →Corewell Health West is the lead sponsor of 16 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Corewell Health General Surgery Patients
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Primary Outcome
Intraoperative Pre and Post hernia sac excision crural tension measurement will be collected.
Time frame: Immediately following procedure
Competeness of hernia sac excision
Determining whether the hernia sac excision was complteted or partial
Time frame: Immediately following procedure
Paraesophageal hernia type
Comparing the paraesophageal hernia type
Time frame: Immediately following procedure
Mesh useage
Comparing the type of mesh used during the procedure
Time frame: Immediately following procedure
Complications
Following patients for post-op complications
Time frame: 30-days post-op
Comparing dephographics
Looking at the patients demographics and comparing them to the above outcomes
Time frame: 30-days post-op
Started Aug 2021 (actual). Primary completion is estimated for Mar 2026, 55 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Corewell Health West